Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects

Anuja Ghorpade1, Yury Persidsky, Susan Swindells

  • 1Laboratory of Cellular Neuroimmunology, 985215 Nebraska Medical Center, Omaha, NE, 68198-5215, USA. aghorpad@unmc.edu

Insights

HIV-1-associated dementia (HAD) involves brain immune cell dysfunction. Researchers found that microglia from HIV-1 patients showed altered immune responses, impacting innate immunity in the brain.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • HIV-1-associated dementia (HAD) pathogenesis involves microglial and macrophage infection and immune activation.
  • Understanding microglial function is crucial for HAD research.

Purpose of the Study:

  • To assess microglial function in the context of HIV-1-associated dementia.
  • To investigate changes in innate immune responses of microglia during HIV-1 infection.

Main Methods:

  • Isolation of microglial cells from post-mortem brain tissues of an HIV-1 infected patient and seronegative controls.
  • Correlation of regional neuropathology with microglial function.
  • Assessment of TNF-alpha secretion (basal and LPS-stimulated) in microglia.
  • Evaluation of monocyte immune responses following repeated LPS activation.

Main Results:

  • Microglia from the HIV-1 patient formed multinucleated giant cells and produced HIV-1 virions.
  • These HIV-1 patient microglia exhibited reduced basal and LPS-stimulated TNF-alpha secretion compared to controls.
  • Monocytes from seronegative donors showed similar diminished immune responses after repeated LPS stimulation.

Conclusions:

  • Viral infection and chronic immune activation significantly alter innate microglial function.
  • These findings highlight changes in microglial immune responses relevant to HIV-1-associated dementia pathogenesis.

Related Concept Videos